Aktsiaselts Fertilitas
Active Registry code 16260520
AS Haabneeme alevik Registered 30 Jun 2021
Aktsiaselts Fertilitas is a AS based in Haabneeme alevik, registry code 16260520, status: active. Main activity: Medical specialists activities. According to EMTA, turnover for Q3 2026 was €25 987 with 187 employees.
Turnover
25 987 €
↓ 3.9% vs Q2 2026
State taxes
483 763 €
↑ 6.5% vs Q2 2026
Labour taxes
501 638 €
↑ 2.6% vs Q2 2026
Employees
187
+1 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 25 987 €above 75% of companiesindustry median 9 428 € · companies in the industry: 351
- Labour taxes per employee 2 683 €above 58% of companiesindustry median 2 177 € · companies in the industry: 1 696
- Revenue · 2025 8.4 mn €above 98% of companiesindustry median 20 811 € · companies in the industry: 3 373
- Net profit margin · 2025 1.2 %above 31% of companiesindustry median 8.3 % · companies in the industry: 2 759
Taxes and turnover
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 25 987 | 483 763 | 501 638 | 187 |
| Q2 2026 | 27 047 | 454 152 | 488 820 | 186 |
| Q1 2026 | 38 414 | 448 984 | 480 792 | 187 |
| Q4 2025 | 42 205 | 456 596 | 484 845 | 187 |
| Q3 2025 | 29 531 | 473 354 | 506 077 | 186 |
| Q2 2025 | 30 830 | 496 554 | 529 855 | 177 |
| Q1 2025 | 28 255 | 472 021 | 501 170 | 182 |
| Q4 2024 | 30 122 | 461 135 | 488 798 | 185 |
| Q3 2024 | 37 469 | 485 490 | 512 425 | 183 |
| Q2 2024 | 38 097 | 485 811 | 510 575 | 181 |
| Q1 2024 | 33 762 | 466 088 | 480 322 | 186 |
| Q4 2023 | 42 681 | 444 922 | 465 913 | 176 |
| Q3 2023 | 45 464 | 447 420 | 468 897 | 172 |
| Q2 2023 | 30 557 | 399 141 | 419 402 | 168 |
| Q1 2023 | — | 398 739 | 420 249 | 168 |
| Q4 2022 | — | 374 836 | 396 330 | 184 |
| Q3 2022 | — | 381 316 | 404 016 | 189 |
| Q2 2022 | — | 370 344 | 392 670 | 194 |
| Q1 2022 | — | 379 176 | 402 384 | 210 |
Labour taxes per employee per month
894 €
Turnover per employee in the quarter
139 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 8 382 861 | 98 243 | 4 692 622 | 2 109 102 | 1 081 492 | 120 |
| 2024 | 8 313 536 | 402 578 | 4 866 852 | 2 149 608 | 1 023 693 | 121 |
| 2023 | 7 763 683 | 429 245 | 4 456 626 | 1 731 640 | 663 179 | 115 |
| 2022 | 6 584 544 | -7 915 | 3 977 816 | 1 603 831 | 314 935 | 120 |
| 2021 | 2 728 308 | 46 912 | 1 592 708 | 1 449 807 | 475 084 | 121 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
1.2 %
Net profit / revenue
Return on equity (ROE)
9.1 %
Net profit / equity
Return on assets (ROA)
4.7 %
Net profit / assets
Equity ratio
51.3 %
Equity / assets
Debt ratio
48.7 %
Liabilities / assets
Current ratio
0.70
Current assets / current liabilities
Revenue per employee
69 910 €
Revenue / average full-time employees
Labour cost per employee per month
3 259 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 15 May 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 15 May 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 23 May 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 28 Apr 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 30 Jun 2021 – 31 Dec 2021 | 19 May 2022 | Company’s own · audited | e-Äriregister |
Board
- Lauri MaisveeBoard member · since 30 Jun 2021
- Siiri HeinsaarBoard member · since 15 Jun 2026
Right of representation
Any member of the management board may represent the public limited company in all transactions.
Owners
No owner information.
Owner in
- 100%
Beneficial owners
- Andres ViisemannMember of a senior management body (management or supervisory board) · since 26 May 2023
Founders and other persons
- Grant Thornton Baltic OÜAudit firm · 7 Jun 2021
- Kaido VeskeChairman of the supervisory board · 9 Jun 2026
- Annika UudeleppSupervisory board member · 9 Jun 2026
- Maarja PärsSupervisory board member · 9 Jun 2026
- Omanikukonto: AKTSIASELTS MEDICUM TERVISHOIUTEENUSEDShareholder · 32 896 € · 9 Jun 2026
Related companies
Activities (EMTAK)
- 86221Medical specialists activities Main
- 86992Other human health activities n.e.c.
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50176642 / 13 14 Oct 2026 |
Second (constitutive) merger entry | In force 14 Oct 2026 |
||
| K 50176642 / 12 4 Sep 2026 |
Commercial pledge deleted | In force 4 Sep 2026 |
||
| Ä 50176642 / 11 15 Jun 2026 |
Amendment entry | In force 15 Jun 2026 |
||
| Ä 50176642 / 10 2 Aug 2024 |
Amendment entry | In force 2 Aug 2024 |
||
| Ä 50176642 / 9 21 Feb 2024 |
Amendment entry | In force 21 Feb 2024 |
||
| Ä 50176642 / 8 15 Dec 2022 |
Amendment entry | In force 15 Dec 2022 |
||
| Ä 50176642 / 7 28 Nov 2022 |
Second (constitutive) merger entry | In force 28 Nov 2022 |
||
| Ä 50176642 / M2 21 Nov 2022 |
Ruling to eliminate deficiencies | 21 Dec 2022 | Deficiencies eliminated 28 Nov 2022 |
|
| K 50176642 / 6 15 Nov 2022 |
Commercial pledge entered | In force 15 Nov 2022 |
||
| Ä 50176642 / 5 30 May 2022 |
Deletion of activities from the registry card | In force 30 May 2022 |
||
| K 50176642 / 4 12 Oct 2021 |
Commercial pledge entered | In force 12 Oct 2021 |
||
| Ä 50176642 / 3 19 Jul 2021 |
Amendment entry | In force 19 Jul 2021 |
||
| Ä 50176642 / 2 30 Jun 2021 |
Third (informative) division entry | In force 30 Jun 2021 |
||
| Ä 50176642 30 Jun 2021 |
First (declaratory) division entry (card of the new company) | In force 30 Jun 2021 |
||
| Ä 50176642 / M1 18 Jun 2021 |
Procedural ruling | In force 18 Jun 2021 |
Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data